CIK 0001601485
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113430072
- Phone
- +1 857-209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-16 | Haqq Christopher | Grant or award · Stock Option (Right to Buy) | +64,643 | 64,643 | ||
| 2026-02-02 | Haqq Christopher | Grant or award | +25,400 | 57,381 | ||
| 2026-02-02 | Haqq Christopher | Grant or award · Stock Option (Right to Buy) | +50,900 | 50,900 | ||
| 2025-02-03 | Haqq Christopher | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2024-09-30 | Haqq Christopher | Grant or award · Stock Option (Right to Buy) | +28,200 | 28,200 | ||
| 2024-02-01 | Haqq Christopher | Grant or award · Stock Option (right to buy) | +28,200 | 28,200 |
Page 1 of 1 · 6 trades